SEC EDGAR filings, ownership reports, and insider transactions for ALNYLAM PHARMACEUTICALS, INC..
Recent SEC filings for ALNYLAM PHARMACEUTICALS, INC. including 4, 144, 8-K and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Jan 2026 | 11 Jan 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Jan 2026 | 11 Jan 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Jan 2026 | 11 Jan 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Jan 2026 | 11 Jan 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Jan 2026 | 11 Jan 2026 | |
| 144 | Open 144 document | View SEC filing for 144 | 13 Jan 2026 | 001-36407 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 12 Jan 2026 | 11 Jan 2026 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jan 2026 | 05 Jan 2026 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 07 Jan 2026 | 05 Jan 2026 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 11 Dec 2025 | 10 Dec 2025 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 03 Dec 2025 | 02 Dec 2025 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Dec 2025 | 26 Nov 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Nov 2025 | 17 Nov 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 17 Nov 2025 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Nov 2025 | 12 Nov 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 12 Nov 2025 | 001-36407 | ||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 05 Nov 2025 | 005-79884 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 30 Oct 2025 | 30 Sep 2025 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 30 Oct 2025 | 30 Oct 2025 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Oct 2025 | 01 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Oct 2025 | 01 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Oct 2025 | 01 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Oct 2025 | 01 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Oct 2025 | 01 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Oct 2025 | 01 Oct 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 03 Oct 2025 | 30 Sep 2025 | 001-36407 |
| 144 | Open 144 document | View SEC filing for 144 | 03 Oct 2025 | 001-36407 | ||
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 22 Sep 2025 | 15 Sep 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 12 Sep 2025 | 12 Sep 2025 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Sep 2025 | 09 Sep 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 10 Sep 2025 | 08 Sep 2025 | 001-36407 |
| 144 | Open 144 document | View SEC filing for 144 | 09 Sep 2025 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Sep 2025 | 29 Aug 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 29 Aug 2025 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Aug 2025 | 15 Aug 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Aug 2025 | 15 Aug 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Aug 2025 | 15 Aug 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Aug 2025 | 15 Aug 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Aug 2025 | 15 Aug 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Aug 2025 | 18 Aug 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 19 Aug 2025 | 001-36407 | ||
| 144 | Open 144 document | View SEC filing for 144 | 18 Aug 2025 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 15 Aug 2025 | 14 Aug 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 14 Aug 2025 | 001-36407 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 31 Jul 2025 | 30 Jun 2025 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 31 Jul 2025 | 31 Jul 2025 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2025 | 01 Jul 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 18 Jun 2025 | 12 Jun 2025 | 001-36407 |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 17 Jun 2025 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jun 2025 | 30 May 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 02 Jun 2025 | 001-36407 | ||
| 144 | Open 144 document | View SEC filing for 144 | 30 May 2025 | 001-36407 | ||
| 144 | Open 144 document | View SEC filing for 144 | 30 May 2025 | 001-36407 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 22 May 2025 | |||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2025 | 15 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2025 | 16 May 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 15 May 2025 | 001-36407 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 13 May 2025 | 08 May 2025 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 May 2025 | 08 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 May 2025 | 08 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 May 2025 | 08 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 May 2025 | 08 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 May 2025 | 08 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 May 2025 | 08 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 May 2025 | 29 Aug 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 May 2025 | 08 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 May 2025 | 08 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 May 2025 | 08 May 2025 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 09 May 2025 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 May 2025 | 02 May 2025 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 01 May 2025 | 31 Mar 2025 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 01 May 2025 | 01 May 2025 | 001-36407 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 07 Apr 2025 | 005-79884 | ||
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 04 Apr 2025 | 001-36407 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Mar 2025 | 21 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Mar 2025 | 24 Mar 2025 | |
| ARS | Open ARS document | View SEC filing for ARS | ARS | 24 Mar 2025 | 31 Dec 2024 | 001-36407 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 24 Mar 2025 | 001-36407 | |
| DEF 14A | Open DEF 14A document | Open XBRL data | View SEC filing for DEF 14A | DEF 14A | 24 Mar 2025 | 08 May 2025 | 001-36407 |
| 144 | Open 144 document | View SEC filing for 144 | 24 Mar 2025 | 001-36407 | ||
| 144 | Open 144 document | View SEC filing for 144 | 24 Mar 2025 | 001-36407 | ||
| 144 | Open 144 document | View SEC filing for 144 | 21 Mar 2025 | 001-36407 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 21 Mar 2025 | 20 Mar 2025 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Mar 2025 | 13 Mar 2025 | |
| PRE 14A | Open PRE 14A document | Open XBRL data | View SEC filing for PRE 14A | PRE 14A | 14 Mar 2025 | 08 May 2025 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 05 Mar 2025 | 03 Mar 2025 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2025 | 03 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2025 | 03 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2025 | 03 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2025 | 03 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2025 | 03 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2025 | 03 Mar 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 04 Mar 2025 | 001-36407 | ||
| 144 | Open 144 document | View SEC filing for 144 | 04 Mar 2025 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Mar 2025 | 27 Feb 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Mar 2025 | 27 Feb 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Mar 2025 | 27 Feb 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Mar 2025 | 27 Feb 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Mar 2025 | 28 Feb 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 03 Mar 2025 | 001-36407 | ||
| 144 | Open 144 document | View SEC filing for 144 | 03 Mar 2025 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 18 Feb 2025 | 13 Feb 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 18 Feb 2025 | 13 Feb 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 18 Feb 2025 | 13 Feb 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 18 Feb 2025 | 13 Feb 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 18 Feb 2025 | 001-36407 | ||
| 144 | Open 144 document | View SEC filing for 144 | 18 Feb 2025 | 001-36407 | ||
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 13 Feb 2025 | 005-79884 | ||
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 13 Feb 2025 | 31 Dec 2024 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 13 Feb 2025 | 13 Feb 2025 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 29 Jan 2025 | 27 Jan 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 27 Jan 2025 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 24 Jan 2025 | 23 Jan 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 23 Jan 2025 | 001-36407 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 13 Jan 2025 | 12 Jan 2025 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Dec 2024 | 12 Dec 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 12 Dec 2024 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Nov 2024 | 25 Nov 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Nov 2024 | 25 Nov 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Nov 2024 | 25 Nov 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Nov 2024 | 25 Nov 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Nov 2024 | 25 Nov 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 27 Nov 2024 | 001-36407 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 12 Nov 2024 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 08 Nov 2024 | 005-79884 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 31 Oct 2024 | 30 Sep 2024 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 31 Oct 2024 | 31 Oct 2024 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 10 Oct 2024 | 08 Oct 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Oct 2024 | 01 Oct 2024 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 03 Oct 2024 | 30 Sep 2024 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 25 Sep 2024 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Aug 2024 | 20 Aug 2024 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 22 Aug 2024 | |||
| 144 | Open 144 document | View SEC filing for 144 | 20 Aug 2024 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Aug 2024 | 12 Aug 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 12 Aug 2024 | 001-36407 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 12 Aug 2024 | 005-79884 | ||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 12 Aug 2024 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 08 Aug 2024 | 06 Aug 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 06 Aug 2024 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Aug 2024 | 01 Aug 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 01 Aug 2024 | 001-36407 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 01 Aug 2024 | 30 Jun 2024 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 01 Aug 2024 | 01 Aug 2024 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 Jul 2024 | 11 Jul 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 11 Jul 2024 | 001-36407 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 05 Jul 2024 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Jun 2024 | 25 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Jun 2024 | 24 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Jun 2024 | 24 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Jun 2024 | 24 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Jun 2024 | 24 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Jun 2024 | 24 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Jun 2024 | 24 Jun 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 25 Jun 2024 | 001-36407 | ||
| 144 | Open 144 document | View SEC filing for 144 | 24 Jun 2024 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 31 May 2024 | 29 May 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 29 May 2024 | 001-36407 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 20 May 2024 | 16 May 2024 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2024 | 16 May 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2024 | 16 May 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2024 | 16 May 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2024 | 16 May 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2024 | 16 May 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2024 | 16 May 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2024 | 16 May 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2024 | 16 May 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2024 | 16 May 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2024 | 16 May 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2024 | 16 May 2024 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 02 May 2024 | 31 Mar 2024 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 02 May 2024 | 02 May 2024 | 001-36407 |
| ARS | Open ARS document | View SEC filing for ARS | ARS | 01 Apr 2024 | 31 Dec 2023 | 001-36407 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 01 Apr 2024 | 001-36407 | |
| DEF 14A | Open DEF 14A document | Open XBRL data | View SEC filing for DEF 14A | DEF 14A | 01 Apr 2024 | 16 May 2024 | 001-36407 |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 28 Mar 2024 | 20 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2024 | 01 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2024 | 01 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2024 | 01 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2024 | 01 Mar 2024 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 04 Mar 2024 | 04 Mar 2024 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2024 | 29 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 29 Feb 2024 | 27 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 29 Feb 2024 | 27 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 29 Feb 2024 | 27 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 29 Feb 2024 | 27 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 29 Feb 2024 | 27 Feb 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 29 Feb 2024 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 Feb 2024 | 15 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 Feb 2024 | 15 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 Feb 2024 | 15 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 Feb 2024 | 15 Feb 2024 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 15 Feb 2024 | 31 Dec 2023 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 15 Feb 2024 | 15 Feb 2024 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 13 Feb 2024 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 09 Feb 2024 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 09 Feb 2024 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 09 Feb 2024 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Feb 2024 | 01 Feb 2024 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 29 Jan 2024 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 26 Jan 2024 | 005-79884 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 19 Jan 2024 | 12 Jan 2024 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 08 Jan 2024 | 07 Jan 2024 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 29 Dec 2023 | 27 Dec 2023 | |
| 144 | Open 144 document | View SEC filing for 144 | 27 Dec 2023 | 001-36407 | ||
| 144 | Open 144 document | View SEC filing for 144 | 11 Dec 2023 | 001-36407 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 02 Nov 2023 | 30 Sep 2023 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 02 Nov 2023 | 02 Nov 2023 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 10 Oct 2023 | 09 Oct 2023 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 28 Sep 2023 | 26 Sep 2023 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Aug 2023 | 03 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Aug 2023 | 03 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Aug 2023 | 03 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Aug 2023 | 03 Aug 2023 | |
| 144 | Open 144 document | View SEC filing for 144 | 07 Aug 2023 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Aug 2023 | 02 Aug 2023 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 03 Aug 2023 | 30 Jun 2023 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 03 Aug 2023 | 31 Jul 2023 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 26 Jul 2023 | 21 Jul 2023 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 30 Jun 2023 | 30 Jun 2023 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 23 May 2023 | 18 May 2023 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2023 | 18 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2023 | 18 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2023 | 18 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2023 | 18 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2023 | 18 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2023 | 18 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2023 | 18 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2023 | 18 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2023 | 18 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 May 2023 | 18 May 2023 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 04 May 2023 | 31 Mar 2023 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 04 May 2023 | 04 May 2023 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Apr 2023 | 26 Apr 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Apr 2023 | 26 Apr 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Apr 2023 | 26 Apr 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Apr 2023 | 26 Apr 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Apr 2023 | 26 Apr 2023 | |
| 144 | Open 144 document | View SEC filing for 144 | 28 Apr 2023 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 10 Apr 2023 | 06 Apr 2023 | |
| ARS | Open ARS document | View SEC filing for ARS | ARS | 03 Apr 2023 | 31 Dec 2022 | 001-36407 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 03 Apr 2023 | 001-36407 | |
| DEF 14A | Open DEF 14A document | Open XBRL data | View SEC filing for DEF 14A | DEF 14A | 03 Apr 2023 | 001-36407 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Mar 2023 | 07 Mar 2023 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 09 Mar 2023 | 07 Mar 2023 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 08 Mar 2023 | 07 Mar 2023 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Mar 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2023 | 27 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2023 | 27 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2023 | 27 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2023 | 27 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2023 | 27 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2023 | 27 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Feb 2023 | 23 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Feb 2023 | 23 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Feb 2023 | 23 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Feb 2023 | 23 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Feb 2023 | 23 Feb 2023 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 23 Feb 2023 | 333-269939 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 23 Feb 2023 | 31 Dec 2022 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 23 Feb 2023 | 23 Feb 2023 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Feb 2023 | 10 Feb 2023 | |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 14 Feb 2023 | 001-36407 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Feb 2023 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 13 Feb 2023 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 09 Feb 2023 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 09 Feb 2023 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 06 Feb 2023 | 005-79884 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Feb 2023 | 01 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Feb 2023 | 01 Feb 2023 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 31 Jan 2023 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 19 Jan 2023 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Jan 2023 | 05 Jan 2023 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 09 Jan 2023 | 05 Jan 2023 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 09 Jan 2023 | 08 Jan 2023 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 06 Jan 2023 | 05 Jan 2023 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Dec 2022 | 05 Dec 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Nov 2022 | 21 Nov 2022 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 27 Oct 2022 | 30 Sep 2022 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 27 Oct 2022 | 27 Oct 2022 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 16 Sep 2022 | 12 Sep 2022 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 13 Sep 2022 | 12 Sep 2022 | 001-36407 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SEC SCHEDULE 13G | 09 Sep 2022 | 005-79884 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 24 Aug 2022 | 19 Aug 2022 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 24 Aug 2022 | 22 Aug 2022 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 24 Aug 2022 | 22 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Aug 2022 | 15 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Aug 2022 | 03 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Aug 2022 | 03 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Aug 2022 | 03 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Aug 2022 | 03 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Aug 2022 | 03 Aug 2022 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 28 Jul 2022 | 30 Jun 2022 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 28 Jul 2022 | 28 Jul 2022 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jul 2022 | 05 Jul 2022 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 14 Jun 2022 | 13 Jun 2022 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 23 May 2022 | 18 May 2022 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2022 | 18 May 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2022 | 18 May 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2022 | 18 May 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2022 | 18 May 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2022 | 18 May 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2022 | 18 May 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2022 | 18 May 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2022 | 18 May 2022 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 28 Apr 2022 | 31 Mar 2022 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 28 Apr 2022 | 28 Apr 2022 | 001-36407 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 05 Apr 2022 | 001-36407 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 05 Apr 2022 | 18 May 2022 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 05 Apr 2022 | 31 Mar 2022 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Apr 2022 | 01 Apr 2022 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 04 Apr 2022 | 04 Apr 2022 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 17 Mar 2022 | 17 Mar 2022 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2022 | 23 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2022 | 23 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2022 | 23 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2022 | 23 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2022 | 23 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2022 | 23 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2022 | 23 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2022 | 23 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2022 | 23 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2022 | 23 Feb 2022 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 14 Feb 2022 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Feb 2022 | 09 Feb 2022 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 10 Feb 2022 | 31 Dec 2021 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 10 Feb 2022 | 10 Feb 2022 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Feb 2022 | 01 Feb 2022 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 09 Feb 2022 | 31 Jan 2022 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 09 Feb 2022 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 09 Feb 2022 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 04 Feb 2022 | 005-79884 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Feb 2022 | 01 Feb 2022 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 03 Feb 2022 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 18 Jan 2022 | 005-79884 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 10 Jan 2022 | 09 Jan 2022 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 04 Jan 2022 | 04 Jan 2022 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Jan 2022 | 31 Dec 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Jan 2022 | 31 Dec 2021 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 04 Jan 2022 | 31 Dec 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Dec 2021 | 21 Dec 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Dec 2021 | 21 Dec 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Dec 2021 | 21 Dec 2021 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 20 Dec 2021 | 14 Dec 2021 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Dec 2021 | 10 Dec 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 Nov 2021 | 12 Nov 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 29 Oct 2021 | 27 Oct 2021 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 28 Oct 2021 | 30 Sep 2021 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 28 Oct 2021 | 26 Oct 2021 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 08 Sep 2021 | 06 Sep 2021 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Aug 2021 | 13 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Aug 2021 | 09 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Aug 2021 | 05 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Aug 2021 | 06 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Aug 2021 | 02 Aug 2021 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 03 Aug 2021 | 30 Jun 2021 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 03 Aug 2021 | 02 Aug 2021 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Jul 2021 | 15 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Jul 2021 | 15 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Jul 2021 | 15 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Jul 2021 | 15 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Jul 2021 | 15 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Jul 2021 | 15 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Jul 2021 | 15 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Jul 2021 | 15 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Jul 2021 | 15 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Jul 2021 | 15 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Jul 2021 | 12 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2021 | 18 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Jun 2021 | 09 Jun 2021 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 21 May 2021 | 18 May 2021 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 May 2021 | 13 May 2021 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 29 Apr 2021 | 31 Mar 2021 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 29 Apr 2021 | 29 Apr 2021 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Apr 2021 | 19 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Apr 2021 | 10 Oct 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Apr 2021 | 19 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Apr 2021 | 19 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Apr 2021 | 19 Apr 2021 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 12 Apr 2021 | 12 Apr 2021 | 001-36407 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 02 Apr 2021 | 001-36407 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 02 Apr 2021 | 18 May 2021 | 001-36407 |
| SEC STAFF LETTER | Open SEC STAFF LETTER document | View SEC filing for SEC STAFF LETTER | 18 Mar 2021 | |||
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 10 Mar 2021 | 09 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Feb 2021 | 24 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Feb 2021 | 24 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Feb 2021 | 24 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Feb 2021 | 24 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Feb 2021 | 24 Feb 2021 | |
| SEC STAFF LETTER | Open SEC STAFF LETTER document | View SEC filing for SEC STAFF LETTER | 18 Feb 2021 | |||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Feb 2021 | 11 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Feb 2021 | 11 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Feb 2021 | 11 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Feb 2021 | 11 Feb 2021 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 11 Feb 2021 | 333-252994 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 11 Feb 2021 | 31 Dec 2020 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 11 Feb 2021 | 11 Feb 2021 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 10 Feb 2021 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 08 Feb 2021 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 03 Feb 2021 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 01 Feb 2021 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 29 Jan 2021 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 15 Jan 2021 | 13 Jan 2021 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Jan 2021 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Jan 2021 | 11 Jan 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Jan 2021 | 12 Jan 2021 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 11 Jan 2021 | 10 Jan 2021 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2020 | 18 Dec 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2020 | 07 Dec 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 30 Nov 2020 | 25 Nov 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 Nov 2020 | 19 Nov 2020 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 05 Nov 2020 | 30 Sep 2020 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 05 Nov 2020 | 05 Nov 2020 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 02 Oct 2020 | 30 Sep 2020 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Oct 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Sep 2020 | 09 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Aug 2020 | 20 Aug 2020 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 20 Aug 2020 | 15 Aug 2020 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Aug 2020 | 10 Aug 2020 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 06 Aug 2020 | 30 Jun 2020 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 06 Aug 2020 | 03 Aug 2020 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Jul 2020 | 13 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Jul 2020 | 10 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 10 Jul 2020 | 09 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Jul 2020 | 07 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jul 2020 | 01 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jul 2020 | 01 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jul 2020 | 01 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jul 2020 | 01 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jul 2020 | 01 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jul 2020 | 01 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jul 2020 | 01 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jul 2020 | 01 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jul 2020 | 01 Jul 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 24 Jun 2020 | 22 Jun 2020 | |
| S-3ASR | Open S-3ASR document | View SEC filing for S-3ASR | S-3ASR | 05 Jun 2020 | 333-238989 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 May 2020 | 20 May 2020 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 11 May 2020 | 06 May 2020 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 May 2020 | 06 May 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 May 2020 | 05 May 2020 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 06 May 2020 | 31 Mar 2020 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 06 May 2020 | 06 May 2020 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Apr 2020 | 20 Apr 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Apr 2020 | 20 Apr 2020 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 13 Apr 2020 | 10 Apr 2020 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Apr 2020 | 07 Apr 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Apr 2020 | 07 Apr 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Apr 2020 | 07 Apr 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Apr 2020 | 07 Apr 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Apr 2020 | 07 Apr 2020 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 06 Apr 2020 | 03 Apr 2020 | 001-36407 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 24 Mar 2020 | 001-36407 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 23 Mar 2020 | 06 May 2020 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Mar 2020 | 02 Mar 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 04 Mar 2020 | 02 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Feb 2020 | 26 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Feb 2020 | 03 Jan 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Feb 2020 | 26 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Feb 2020 | 26 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Feb 2020 | 26 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Feb 2020 | 26 Feb 2020 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 27 Feb 2020 | 26 Feb 2020 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Feb 2020 | 20 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Feb 2020 | 12 Feb 2020 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 13 Feb 2020 | 333-236409 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 13 Feb 2020 | 31 Dec 2019 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 12 Feb 2020 | 10 Feb 2020 | |
| 4/A | Open 4/A document | View SEC filing for 4/A | PRIMARY DOCUMENT | 12 Feb 2020 | 27 Jan 2020 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 12 Feb 2020 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 12 Feb 2020 | 005-79884 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Feb 2020 | 10 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Feb 2020 | 07 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Feb 2020 | 07 Feb 2020 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 07 Feb 2020 | 005-79884 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 06 Feb 2020 | 06 Feb 2020 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 05 Feb 2020 | 005-79884 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 03 Feb 2020 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 31 Jan 2020 | 29 Jan 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 29 Jan 2020 | 27 Jan 2020 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 28 Jan 2020 | 005-79884 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 13 Jan 2020 | 12 Jan 2020 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Dec 2019 | 23 Dec 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Dec 2019 | 23 Dec 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Dec 2019 | 23 Dec 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Dec 2019 | 23 Dec 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Dec 2019 | 23 Dec 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Dec 2019 | 12 Dec 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Nov 2019 | 22 Nov 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Nov 2019 | 22 Nov 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Nov 2019 | 22 Nov 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Nov 2019 | 22 Nov 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Nov 2019 | 22 Nov 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Nov 2019 | 20 Nov 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Nov 2019 | 20 Nov 2019 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 20 Nov 2019 | 20 Nov 2019 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 Nov 2019 | 18 Nov 2019 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 31 Oct 2019 | 30 Sep 2019 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 31 Oct 2019 | 31 Oct 2019 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 24 Oct 2019 | 22 Oct 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Oct 2019 | 14 Oct 2019 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 03 Oct 2019 | 27 Sep 2019 | 001-36407 |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 13 Aug 2019 | 13 Aug 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Aug 2019 | 06 Aug 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Aug 2019 | 06 Aug 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Aug 2019 | 06 Aug 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Aug 2019 | 06 Aug 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Aug 2019 | 06 Aug 2019 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 06 Aug 2019 | 30 Jun 2019 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 06 Aug 2019 | 06 Aug 2019 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 11 Jul 2019 | 08 Jul 2019 | 001-36407 |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 05 Jul 2019 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2019 | 01 Jul 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2019 | 01 Jul 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2019 | 01 Jul 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2019 | 01 Jul 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2019 | 01 Jul 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2019 | 01 Jul 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2019 | 01 Jul 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2019 | 01 Jul 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2019 | 01 Jul 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2019 | 01 Jul 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2019 | 05 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2019 | 05 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2019 | 05 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2019 | 05 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2019 | 05 Jun 2019 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 21 May 2019 | 21 May 2019 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 May 2019 | 15 May 2019 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 03 May 2019 | 005-79884 | |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 02 May 2019 | 333-113162 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | MARCH 31, 2019 FORM 10-Q | 02 May 2019 | 31 Mar 2019 | 001-36407 |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 02 May 2019 | 000-50743 | ||
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 02 May 2019 | 000-50743 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 01 May 2019 | 01 May 2019 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 26 Apr 2019 | 25 Apr 2019 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Apr 2019 | 15 Apr 2019 | |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 10 Apr 2019 | 001-36407 | |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 10 Apr 2019 | 000-50743 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 09 Apr 2019 | 08 Apr 2019 | 001-36407 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 08 Apr 2019 | 001-36407 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 21 Mar 2019 | |||
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 21 Mar 2019 | 25 Apr 2019 | 001-36407 |
| PRER14A | Open PRER14A document | View SEC filing for PRER14A | PRER14A | 18 Mar 2019 | 001-36407 | |
| PRE 14A | Open PRE 14A document | View SEC filing for PRE 14A | PRE 14A | 11 Mar 2019 | 25 Apr 2019 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2019 | 28 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2019 | 28 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2019 | 28 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2019 | 28 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2019 | 28 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Mar 2019 | 28 Feb 2019 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 14 Feb 2019 | 31 Dec 2018 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Feb 2019 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G AMENDMENT 3 | 14 Feb 2019 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 13 Feb 2019 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 12 Feb 2019 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 11 Feb 2019 | 005-79884 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 07 Feb 2019 | 07 Feb 2019 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 04 Feb 2019 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 31 Jan 2019 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jan 2019 | 17 Jan 2019 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 15 Jan 2019 | 14 Jan 2019 | 001-36407 |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424B5 | 15 Jan 2019 | 333-217688 | |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424B5 | 14 Jan 2019 | 333-217688 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Jan 2019 | 10 Jan 2019 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 11 Jan 2019 | 10 Jan 2019 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 07 Jan 2019 | 07 Jan 2019 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 10 Dec 2018 | 09 Dec 2018 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Nov 2018 | 21 Nov 2018 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | Q3 2018 FORM 10-Q | 07 Nov 2018 | 30 Sep 2018 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 07 Nov 2018 | 07 Nov 2018 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 10 Oct 2018 | 09 Oct 2018 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 02 Oct 2018 | 27 Sep 2018 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Sep 2018 | 27 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Sep 2018 | 27 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Sep 2018 | 27 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Sep 2018 | 27 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Sep 2018 | 27 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Sep 2018 | 27 Sep 2018 | |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 12 Sep 2018 | 000-50743 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Sep 2018 | 30 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Aug 2018 | 21 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Aug 2018 | 21 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Aug 2018 | 21 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Aug 2018 | 21 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Aug 2018 | 21 Aug 2018 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 17 Aug 2018 | 14 Aug 2018 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Aug 2018 | 10 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Aug 2018 | 10 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Aug 2018 | 10 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Aug 2018 | 13 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Aug 2018 | 10 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Aug 2018 | 10 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Aug 2018 | 13 Aug 2018 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 10 Aug 2018 | 10 Aug 2018 | 001-36407 |
| S-8 POS | Open S-8 POS document | View SEC filing for S-8 POS | S-8 POS | 02 Aug 2018 | 333-219840 | |
| S-8 POS | Open S-8 POS document | View SEC filing for S-8 POS | S-8 POS | 02 Aug 2018 | 333-207251 | |
| S-8 POS | Open S-8 POS document | View SEC filing for S-8 POS | S-8 POS | 02 Aug 2018 | 333-190498 | |
| S-8 POS | Open S-8 POS document | View SEC filing for S-8 POS | S-8 POS | 02 Aug 2018 | 333-165105 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 02 Aug 2018 | 333-226533 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | Q2 2018 FORM 10-Q | 02 Aug 2018 | 30 Jun 2018 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 02 Aug 2018 | 02 Aug 2018 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Jul 2018 | 25 Jul 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2018 | 16 Apr 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2018 | 20 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2018 | 20 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2018 | 20 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2018 | 20 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2018 | 20 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2018 | 20 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2018 | 20 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2018 | 20 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Jun 2018 | 20 Jun 2018 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 11 Jun 2018 | 005-79884 | ||
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 05 Jun 2018 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Jun 2018 | 01 Jun 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 04 Jun 2018 | 01 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Jun 2018 | 31 May 2018 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 15 May 2018 | 10 May 2018 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 10 May 2018 | 005-79884 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | Q1'18 10-Q | 04 May 2018 | 31 Mar 2018 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 03 May 2018 | 03 May 2018 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 20 Apr 2018 | 18 Apr 2018 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 03 Apr 2018 | 28 Mar 2018 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Mar 2018 | 26 Mar 2018 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 23 Mar 2018 | 10 May 2018 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Mar 2018 | 20 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Mar 2018 | 14 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Mar 2018 | 14 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Mar 2018 | 12 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Mar 2018 | 13 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Mar 2018 | 13 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Mar 2018 | 13 Mar 2018 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 14 Mar 2018 | 08 Mar 2018 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Mar 2018 | 09 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2018 | 01 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2018 | 01 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2018 | 01 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2018 | 01 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2018 | 01 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2018 | 01 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Mar 2018 | 01 Mar 2018 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 15 Feb 2018 | 31 Dec 2017 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Feb 2018 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 13 Feb 2018 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 13 Feb 2018 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 12 Feb 2018 | 005-79884 | ||
| 5 | Open 5 document | View SEC filing for 5 | PRIMARY DOCUMENT | 09 Feb 2018 | 31 Dec 2017 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G AMENDMENT NO 2 | 09 Feb 2018 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 08 Feb 2018 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 08 Feb 2018 | 005-79884 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 08 Feb 2018 | 08 Feb 2018 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 02 Feb 2018 | 005-79884 | ||
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 24 Jan 2018 | 001-36407 | ||
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 24 Jan 2018 | 001-36407 | ||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 23 Jan 2018 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 19 Jan 2018 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 10 Jan 2018 | |||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 08 Jan 2018 | 04 Jan 2018 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 08 Jan 2018 | 06 Jan 2018 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jan 2018 | 30 Dec 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jan 2018 | 29 Dec 2017 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 03 Jan 2018 | 27 Dec 2017 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Dec 2017 | 20 Dec 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Dec 2017 | 20 Dec 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Dec 2017 | 20 Dec 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Dec 2017 | 20 Dec 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Dec 2017 | 20 Dec 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Dec 2017 | 19 Dec 2017 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 11 Dec 2017 | |||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | ALNY AS OF 11/30/2017 | 11 Dec 2017 | 005-79884 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Dec 2017 | 01 Dec 2017 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 28 Nov 2017 | |||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 24 Nov 2017 | 22 Nov 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Nov 2017 | 15 Nov 2017 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 14 Nov 2017 | 13 Nov 2017 | 001-36407 |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424B5 | 14 Nov 2017 | 333-217688 | |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424(B)(5) | 13 Nov 2017 | 333-217688 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 08 Nov 2017 | 06 Nov 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 08 Nov 2017 | 06 Nov 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 08 Nov 2017 | 06 Nov 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 08 Nov 2017 | 06 Nov 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 08 Nov 2017 | 06 Nov 2017 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | Q3'17 FORM 10-Q | 07 Nov 2017 | 30 Sep 2017 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 07 Nov 2017 | 07 Nov 2017 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Nov 2017 | 02 Nov 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 01 Nov 2017 | 30 Oct 2017 | |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 24 Oct 2017 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Oct 2017 | 02 Oct 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Sep 2017 | 20 Sep 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Sep 2017 | 20 Sep 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Sep 2017 | 20 Sep 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Sep 2017 | 20 Sep 2017 | |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 12 Sep 2017 | 000-50743 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 07 Sep 2017 | 07 Sep 2017 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 09 Aug 2017 | ||
| S-8 | Open S-8 document | View SEC filing for S-8 | FORM S-8 | 09 Aug 2017 | 333-219840 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 Aug 2017 | 30 Jun 2017 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 09 Aug 2017 | 09 Aug 2017 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Jul 2017 | 07 Jul 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Jul 2017 | 07 Jul 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Jul 2017 | 07 Jul 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Jul 2017 | 07 Jul 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 11 Jul 2017 | 07 Jul 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 15 Jun 2017 | 13 Jun 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2017 | 02 Jun 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2017 | 02 Jun 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2017 | 02 Jun 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2017 | 02 Jun 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2017 | 02 Jun 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2017 | 02 Jun 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2017 | 02 Jun 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2017 | 02 Jun 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2017 | 02 Jun 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2017 | 02 Jun 2017 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 06 Jun 2017 | 06 Jun 2017 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 01 Jun 2017 | 31 May 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 31 May 2017 | 30 May 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 May 2017 | 23 May 2017 | |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424B5 | 25 May 2017 | 333-217688 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 25 May 2017 | 23 May 2017 | 001-36407 |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424B5 | 23 May 2017 | 333-217688 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 May 2017 | 16 May 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 May 2017 | 15 May 2017 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 09 May 2017 | 09 May 2017 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 09 May 2017 | 08 May 2017 | 001-36407 |
| S-3ASR | Open S-3ASR document | View SEC filing for S-3ASR | S-3ASR | 05 May 2017 | 333-217688 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 05 May 2017 | 31 Mar 2017 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 05 May 2017 | 02 May 2017 | 001-36407 |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEFINITIVE PROXY STATEMENT | 17 Mar 2017 | 02 May 2017 | 001-36407 |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 15 Feb 2017 | 31 Dec 2016 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G AMENDMENT NO. 1 | 14 Feb 2017 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Feb 2017 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 13 Feb 2017 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 13 Feb 2017 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 09 Feb 2017 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 09 Feb 2017 | 005-79884 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 08 Feb 2017 | 08 Feb 2017 | 001-36407 |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 07 Feb 2017 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Feb 2017 | 01 Feb 2017 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 30 Jan 2017 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Jan 2017 | 25 Jan 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 Jan 2017 | 18 Jan 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jan 2017 | 05 Jan 2017 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Jan 2017 | 30 Dec 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jan 2017 | 30 Dec 2016 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 03 Jan 2017 | 29 Dec 2016 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2016 | 20 Dec 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2016 | 20 Dec 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2016 | 20 Dec 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2016 | 20 Dec 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2016 | 20 Dec 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2016 | 20 Dec 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2016 | 20 Dec 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Dec 2016 | 12 Dec 2016 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SCHEDULE 13G | 09 Dec 2016 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 09 Dec 2016 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Dec 2016 | 01 Dec 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Dec 2016 | 30 Nov 2016 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | FORM 10-Q | 03 Nov 2016 | 30 Sep 2016 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 02 Nov 2016 | 02 Nov 2016 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Oct 2016 | 13 Oct 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Oct 2016 | 12 Oct 2016 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 05 Oct 2016 | 05 Oct 2016 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Sep 2016 | 19 Sep 2016 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 21 Sep 2016 | 19 Sep 2016 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 19 Sep 2016 | 19 Sep 2016 | 001-36407 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | FORM 10-Q | 04 Aug 2016 | 30 Jun 2016 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 04 Aug 2016 | 04 Aug 2016 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Jul 2016 | 19 Jul 2016 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 15 Jun 2016 | 09 Jun 2016 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2016 | 03 Jun 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2016 | 03 Jun 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2016 | 03 Jun 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2016 | 03 Jun 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2016 | 03 Jun 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2016 | 03 Jun 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2016 | 03 Jun 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2016 | 03 Jun 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2016 | 03 Jun 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 07 Jun 2016 | 03 Jun 2016 | |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 19 May 2016 | 001-36407 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 06 May 2016 | 03 May 2016 | 001-36407 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 04 May 2016 | 31 Mar 2016 | 001-36407 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 02 May 2016 | 29 Apr 2016 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Apr 2016 | 19 Apr 2016 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 08 Apr 2016 | 04 Apr 2016 | 001-36407 |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 04 Apr 2016 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Mar 2016 | 24 Mar 2016 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 17 Mar 2016 | 03 May 2016 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 10 Mar 2016 | 09 Mar 2016 | |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 09 Mar 2016 | 000-50743 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 01 Mar 2016 | 005-79884 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2016 | 23 Feb 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 24 Feb 2016 | 22 Feb 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 24 Feb 2016 | 23 Feb 2016 | 001-35670 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 12 Feb 2016 | 005-79884 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | FORM 10-K | 12 Feb 2016 | 31 Dec 2015 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 12 Feb 2016 | 005-79884 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 11 Feb 2016 | 11 Feb 2016 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 11 Feb 2016 | 005-79884 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 10 Feb 2016 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 09 Feb 2016 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Feb 2016 | 01 Feb 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Feb 2016 | 01 Feb 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Feb 2016 | 01 Feb 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Feb 2016 | 01 Feb 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Feb 2016 | 01 Feb 2016 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Feb 2016 | 01 Feb 2016 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 28 Jan 2016 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Jan 2016 | 19 Jan 2016 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 11 Jan 2016 | 11 Jan 2016 | 001-36407 |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 23 Dec 2015 | |||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2015 | 18 Dec 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2015 | 18 Dec 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2015 | 18 Dec 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2015 | 18 Dec 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2015 | 18 Dec 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2015 | 18 Dec 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2015 | 19 Nov 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2015 | 18 Dec 2015 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 22 Dec 2015 | 18 Dec 2015 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 22 Dec 2015 | 18 Dec 2015 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 18 Dec 2015 | 18 Dec 2015 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 09 Dec 2015 | 07 Dec 2015 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 09 Dec 2015 | |||
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 08 Dec 2015 | 000-50743 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Dec 2015 | 04 Dec 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Dec 2015 | 02 Dec 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 30 Nov 2015 | 25 Nov 2015 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 25 Nov 2015 | |||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 Nov 2015 | 20 Nov 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2015 | 11 Nov 2015 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | FORM 10-Q | 09 Nov 2015 | 30 Sep 2015 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 09 Nov 2015 | 09 Nov 2015 | 001-36407 |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 05 Oct 2015 | 001-36407 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 02 Oct 2015 | 02 Oct 2015 | 001-36407 |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 02 Oct 2015 | 333-207251 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | FORM 10-Q | 07 Aug 2015 | 30 Jun 2015 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Aug 2015 | 04 Aug 2015 | |
| 15-12B | Open 15-12B document | View SEC filing for 15-12B | 15-12B | 06 Aug 2015 | 001-36407 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 06 Aug 2015 | 06 Aug 2015 | 001-36407 |
| 25 | Open 25 document | View SEC filing for 25 | FORM 25 | 27 Jul 2015 | 001-36407 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 14 Jul 2015 | 14 Jul 2015 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 10 Jul 2015 | 06 Jul 2015 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 18 Jun 2015 | 16 Jun 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 10 Jun 2015 | 08 Jun 2015 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 10 Jun 2015 | 08 Jun 2015 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 10 Jun 2015 | 08 Jun 2015 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jun 2015 | 01 Jun 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jun 2015 | 01 Jun 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jun 2015 | 01 Jun 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jun 2015 | 01 Jun 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jun 2015 | 01 Jun 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jun 2015 | 01 Jun 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jun 2015 | 01 Jun 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jun 2015 | 01 Jun 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jun 2015 | 01 Jun 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 03 Jun 2015 | 01 Jun 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 May 2015 | 26 May 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 May 2015 | 12 May 2015 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | FORM 10-Q | 08 May 2015 | 31 Mar 2015 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 07 May 2015 | 07 May 2015 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 May 2015 | 01 May 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 May 2015 | 01 May 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 May 2015 | 01 May 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 May 2015 | 01 May 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 May 2015 | 01 May 2015 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 05 May 2015 | 01 May 2015 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Apr 2015 | 21 Apr 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 Apr 2015 | 21 Apr 2015 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 06 Apr 2015 | 03 Apr 2015 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Mar 2015 | 17 Mar 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Mar 2015 | 19 Mar 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Mar 2015 | 17 Mar 2015 | |
| ARS | Open ARS document | View SEC filing for ARS | AUTO-GENERATED PAPER DOCUMENT | 16 Mar 2015 | 31 Dec 2014 | 001-36407 |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 10 Mar 2015 | 01 May 2015 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Mar 2015 | 05 Mar 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Feb 2015 | 25 Feb 2015 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | FORM 10-K | 13 Feb 2015 | 31 Dec 2014 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 13 Feb 2015 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G AMENDMENT NO. 1 | 12 Feb 2015 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 12 Feb 2015 | 12 Feb 2015 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | ALNY AS OF 12/31/2014 | 12 Feb 2015 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 12 Feb 2015 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 06 Feb 2015 | 005-79884 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 03 Feb 2015 | 03 Feb 2015 | 001-36407 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 02 Feb 2015 | 005-79884 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 02 Feb 2015 | 29 Jan 2015 | |
| 4/A | Open 4/A document | View SEC filing for 4/A | 4/A | 02 Feb 2015 | 22 Jan 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Jan 2015 | 26 Jan 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 28 Jan 2015 | 26 Jan 2015 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 28 Jan 2015 | 22 Jan 2015 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 26 Jan 2015 | 20 Jan 2015 | 001-36407 |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424B5 | 21 Jan 2015 | 333-185658 | |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424B5 | 20 Jan 2015 | 333-185658 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 14 Jan 2015 | 08 Jan 2015 | 001-36407 |
| 10-Q/A | Open 10-Q/A document | View SEC filing for 10-Q/A | FORM 10-Q AMENDMENT NO. 1 | 09 Jan 2015 | 31 Mar 2014 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 08 Jan 2015 | 08 Jan 2015 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 05 Jan 2015 | 31 Dec 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 22 Dec 2014 | 19 Dec 2014 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 19 Dec 2014 | 17 Dec 2014 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 18 Dec 2014 | 17 Dec 2014 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 18 Dec 2014 | 17 Dec 2014 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 18 Dec 2014 | 17 Dec 2014 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Dec 2014 | 12 Dec 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Dec 2014 | 12 Dec 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Dec 2014 | 12 Dec 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Dec 2014 | 12 Dec 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 Dec 2014 | 12 Dec 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 10 Dec 2014 | 08 Dec 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 10 Dec 2014 | 08 Dec 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Nov 2014 | 18 Nov 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Nov 2014 | 17 Nov 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2014 | 11 Nov 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2014 | 11 Nov 2014 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 06 Nov 2014 | 30 Sep 2014 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 05 Nov 2014 | 05 Nov 2014 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 30 Oct 2014 | 28 Oct 2014 | |
| 4/A | Open 4/A document | View SEC filing for 4/A | FORM 4/A SUBMISSION | 28 Oct 2014 | 22 Oct 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 24 Oct 2014 | 22 Oct 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 24 Oct 2014 | 22 Oct 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 17 Oct 2014 | 15 Oct 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 15 Oct 2014 | 13 Oct 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Oct 2014 | 08 Oct 2014 | 001-35670 |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 03 Oct 2014 | 25 Sep 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Oct 2014 | 01 Oct 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 26 Sep 2014 | 24 Sep 2014 | 001-35670 |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 26 Sep 2014 | 25 Sep 2014 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 26 Sep 2014 | 24 Sep 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Sep 2014 | 17 Sep 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Sep 2014 | 17 Sep 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Sep 2014 | 16 Sep 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Sep 2014 | 10 Sep 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Sep 2014 | 03 Sep 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Aug 2014 | 27 Aug 2014 | 001-35670 |
| ARS | Open ARS document | View SEC filing for ARS | AUTO-GENERATED PAPER DOCUMENT | 26 Aug 2014 | 31 Dec 2013 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Aug 2014 | 20 Aug 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 Aug 2014 | 18 Aug 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Aug 2014 | 13 Aug 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2014 | 06 Aug 2014 | 001-35670 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | FORM 10-Q | 08 Aug 2014 | 30 Jun 2014 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS 8-K | 07 Aug 2014 | 07 Aug 2014 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 01 Aug 2014 | 30 Jul 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 25 Jul 2014 | 23 Jul 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Jul 2014 | 16 Jul 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jul 2014 | 09 Jul 2014 | 001-35670 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 10 Jul 2014 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jul 2014 | 02 Jul 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 02 Jul 2014 | 01 Jul 2014 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 02 Jul 2014 | 01 Jul 2014 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 02 Jul 2014 | 01 Jul 2014 | 001-36407 |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 30 Jun 2014 | 001-36407 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 27 Jun 2014 | 25 Jun 2014 | 001-35670 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Jun 2014 | 25 Jun 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 19 Jun 2014 | 17 Jun 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2014 | 05 Jun 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2014 | 05 Jun 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2014 | 05 Jun 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2014 | 05 Jun 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2014 | 05 Jun 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2014 | 05 Jun 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 06 Jun 2014 | 05 Jun 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 23 May 2014 | 21 May 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 May 2014 | 19 May 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 16 May 2014 | 14 May 2014 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 May 2014 | 31 Mar 2014 | 001-36407 |
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 08 May 2014 | 08 May 2014 | 001-36407 |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 29 Apr 2014 | 25 Sep 2014 | 001-36407 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 15 Apr 2014 | 14 Apr 2014 | |
| 8-A12B | Open 8-A12B document | View SEC filing for 8-A12B | 8-A12B | 08 Apr 2014 | 001-36407 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 02 Apr 2014 | 27 Mar 2014 | 000-50743 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 27 Mar 2014 | 25 Mar 2014 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 24 Mar 2014 | 18 Mar 2014 | 000-50743 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 Mar 2014 | 18 Mar 2014 | |
| CT ORDER | Open CT ORDER document | View SEC filing for CT ORDER | 07 Mar 2014 | 000-50743 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 06 Mar 2014 | 05 Mar 2014 | 000-50743 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 05 Mar 2014 | 005-79884 | |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 03 Mar 2014 | 27 Feb 2014 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 27 Feb 2014 | 27 Feb 2014 | 000-50743 |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 26 Feb 2014 | 21 Feb 2014 | 000-50743 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 25 Feb 2014 | 21 Feb 2014 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 20 Feb 2014 | 31 Dec 2013 | 000-50743 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 Feb 2014 | 19 Feb 2014 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | DISCLOSURE DOCUMENT | 14 Feb 2014 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Feb 2014 | 005-79884 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 13 Feb 2014 | 13 Feb 2014 | 000-50743 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | ALNY AS OF 12/31/2013 | 12 Feb 2014 | 005-79884 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 12 Feb 2014 | 005-79884 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Feb 2014 | 03 Feb 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Feb 2014 | 03 Feb 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 04 Feb 2014 | 03 Feb 2014 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 04 Feb 2014 | 005-79884 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 28 Jan 2014 | 005-79884 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Jan 2014 | 23 Jan 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Jan 2014 | 23 Jan 2014 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 27 Jan 2014 | 23 Jan 2014 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 15 Jan 2014 | |||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 Jan 2014 | 13 Jan 2014 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 13 Jan 2014 | 11 Jan 2014 | 000-50743 |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 13 Jan 2014 | 10 Jan 2014 | 000-50743 |
ALNYLAM PHARMACEUTICALS, INC. files with the SEC under CIK 0001178670. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.